Journal
CANCER CELL
Volume 17, Issue 4, Pages 348-361Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2010.01.022
Keywords
-
Categories
Funding
- NSF
- American Cancer Society
- Alfred P. Sloan Research
- National Institutes of Health [HG2966, CA57486, HG4069-02, CA107486]
Ask authors/readers for more resources
Transcriptional profiling of two isogenic models of transformation identifies a gene signature linking cancer with inflammatory and metabolic diseases. In accord with this common transcriptional program, many drugs used for treatment of diabetes and cardiovascular diseases inhibit transformation and tumor growth. Unexpectedly, lipid metabolism genes are important for transformation and are upregulated in cancer tissues. As in atherosclerosis, oxidized LDL and its receptor OLR1 activate the inflammatory pathway through NF-kappa B, leading to transformation. OLR1 is important for maintaining the transformed state in developmentally diverse cancer cell lines and for tumor growth, suggesting a molecular connection between cancer and atherosclerosis. We suggest that the interplay between this common transcriptional program and cell-type-specific factors gives rise to phenotypically disparate human diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available